Transition to adult care for cancer risk patients
Part of Cancer, Genetic & congenital clinical trials.
This study looks at how young adults with a genetic risk for cancer (cancer predisposition syndrome) transition from St. Jude children's care to adult healthcare. It aims to understand their health outcomes and help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a genetic condition that increases your cancer risk (called a cancer predisposition syndrome).
- You have been a patient at St. Jude Cancer Predisposition Clinic for at least 3 years before leaving St. Jude.
- You need regular cancer screening tests as an adult (based on expert guidelines for your condition).
- You speak English fluently.
- You are able to make your own medical decisions (not legally dependent on someone else).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how parents and children communicate after learning about an inherited (genetic) cancer risk. It may help researchers find better ways to support families in these conversations.
This study looks at whether DNA (from a tumor or related samples) can help identify inherited cancer risk in people who develop cancer at a young age. It may help families learn more about risk factors and guide future screening or prevention.
This study looks at how teens and young adults with tough-to-treat cancers, and their families, want to hear news about their cancer. It will help doctors learn the best ways to share information during check-ups and scans.
This study follows people who were treated for childhood cancer and compares them with similar adults who did not have that childhood cancer. It aims to learn about long-term health and especially walking or mobility issues over time, using check-ins that may include a mobility assessment.
This study looks at genetic (DNA) differences to better understand why treatments work differently for children at St. Jude. It may help doctors choose safer or more effective treatments in the future.
This study collects children’s normal and tumor tissue (or blood-related normal samples) and reads their DNA/RNA to look at genetic information. It may help researchers understand cancer-related changes and improve future testing, even when the goal isn’t to treat you directly.
Hear when a new Genetic Predisposition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.